Anavex Life Sciences (AVXL) Shares Outstanding (Entity) (2010 - 2025)
Anavex Life Sciences (AVXL) Shares Outstanding (Entity) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | Anavex Life Sciences | 214.12 Mn | 82.37 Mn | - | 92.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 92.67 Mn |
| Sep 30, 2025 | 86.67 Mn |
| Jun 30, 2025 | 85.41 Mn |
| Mar 31, 2025 | 85.33 Mn |
| Dec 31, 2024 | 84.99 Mn |
| Sep 30, 2024 | 84.80 Mn |
| Jun 30, 2024 | 84.80 Mn |
| Mar 31, 2024 | 83.62 Mn |
| Dec 31, 2023 | 82.09 Mn |
| Sep 30, 2023 | 82.07 Mn |
| Jun 30, 2023 | 81.39 Mn |
| Mar 31, 2023 | 80.24 Mn |
| Dec 31, 2022 | 78.03 Mn |
| Sep 30, 2022 | 77.94 Mn |
| Jun 30, 2022 | 77.94 Mn |
| Mar 31, 2022 | 77.16 Mn |
| Dec 31, 2021 | 76.16 Mn |
| Sep 30, 2021 | 75.92 Mn |
| Jun 30, 2021 | 75.15 Mn |
| Mar 31, 2021 | 70.03 Mn |